Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

被引:215
作者
Devaud, Christel [1 ]
John, Liza B. [1 ]
Westwood, Jennifer A. [1 ]
Darcy, Phillip K. [1 ,2 ]
Kershaw, Michael H. [1 ,2 ]
机构
[1] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Canc Immunol Res Program, Parkville, Vic 3052, Australia
[2] Monash Univ, Dept Immunol, Prahran, Vic, Australia
关键词
immunotherapy; tumor microenvironment; regulatory T cells; macrophages; immunosuppression; T-CELL THERAPY; GAMMA-INDUCIBLE PROTEIN-10; INDOLEAMINE 2,3-DIOXYGENASE; ANTITUMOR IMMUNITY; REGULATORY T; SUPPRESSOR-CELLS; DENDRITIC CELLS; INTRATUMORAL COINJECTION; POTENTIAL MECHANISM; SYSTEMIC DELIVERY;
D O I
10.4161/onci.25961
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
There is much promise in the use of immunotherapy for the treatment of cancer. approaches such as those using antibodies or adoptive cell transfer can mediate complete tumor regression in a proportion of patients. However, the tumor microenvironment can inhibit immune responses leading to ineffective or suboptimal responses of tumors to immunotherapy in the majority of cases. as our knowledge of the tumor microenvironment increases, many strategies are emerging for changing the immunosuppressive nature of the tumor toward a microenvironment able to support immunity. These strategies aim to enhance the ability of immunotherapies to initiate effective immune responses able to destroy tumors. In this article, we review approaches that use immunomodulators specifically to modify the tumor microenvironment, and their use in combination with other immune-based strategies for cancer therapy.
引用
收藏
页数:9
相关论文
共 97 条
[1]
Enhancement of the anti-melanoma response of Hu14.18K322A by αCD40+CpG [J].
Alderson, Kory L. ;
Luangrath, Mitchell ;
Elsenheimer, Megan M. ;
Gillies, Stephen D. ;
Navid, Fariba ;
Rakhmilevich, Alexander L. ;
Sondel, Paul M. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (04) :665-675
[2]
Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice [J].
Amos, Sally M. ;
Pegram, Hollie J. ;
Westwood, Jennifer A. ;
John, Liza B. ;
Devaud, Christel ;
Clarke, Chris J. ;
Restifo, Nicholas P. ;
Smyth, Mark J. ;
Darcy, Phillip K. ;
Kershaw, Michael H. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (05) :671-683
[3]
Aruga A, 1997, J IMMUNOL, V159, P664
[4]
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans [J].
Beatty, Gregory L. ;
Chiorean, Elena G. ;
Fishman, Matthew P. ;
Saboury, Babak ;
Teitelbaum, Ursina R. ;
Sun, Weijing ;
Huhn, Richard D. ;
Song, Wenru ;
Li, Dongguang ;
Sharp, Leslie L. ;
Torigian, Drew A. ;
O'Dwyer, Peter J. ;
Vonderheide, Robert H. .
SCIENCE, 2011, 331 (6024) :1612-1616
[5]
Changing the Tumor Microenvironment: New Strategies for Immunotherapy [J].
Berraondo, Pedro ;
Umansky, Viktor ;
Melero, Ignacio .
CANCER RESEARCH, 2012, 72 (20) :5159-5164
[6]
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates [J].
Brahmer, Julie R. ;
Drake, Charles G. ;
Wollner, Ira ;
Powderly, John D. ;
Picus, Joel ;
Sharfman, William H. ;
Stankevich, Elizabeth ;
Pons, Alice ;
Salay, Theresa M. ;
McMiller, Tracee L. ;
Gilson, Marta M. ;
Wang, Changyu ;
Selby, Mark ;
Taube, Janis M. ;
Anders, Robert ;
Chen, Lieping ;
Korman, Alan J. ;
Pardoll, Drew M. ;
Lowy, Israel ;
Topalian, Suzanne L. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) :3167-3175
[7]
Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages [J].
Buhtoiarov, Ilia N. ;
Sondel, Paul M. ;
Wigginton, Jon M. ;
Buhtoiarova, Tatiana N. ;
Yanke, Eric M. ;
Mahvi, David A. ;
Rakhmilevich, Alexander L. .
IMMUNOLOGY, 2011, 132 (02) :226-239
[8]
Local Delivery of Interleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice [J].
Chinnasamy, Dhanalakshmi ;
Yu, Zhiya ;
Kerkar, Sid P. ;
Zhang, Ling ;
Morgan, Richard A. ;
Restifo, Nicholas P. ;
Rosenberg, Steven A. .
CLINICAL CANCER RESEARCH, 2012, 18 (06) :1672-1683
[9]
IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression [J].
Chmielewski, Markus ;
Kopecky, Caroline ;
Hombach, Andreas A. ;
Abken, Hinrich .
CANCER RESEARCH, 2011, 71 (17) :5697-5706
[10]
Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells [J].
Cole, C ;
Qiao, J ;
Kottke, T ;
Diaz, RM ;
Ahmed, A ;
Sanchez-Perez, L ;
Brunn, G ;
Thompson, J ;
Chester, J ;
Vile, RG .
NATURE MEDICINE, 2005, 11 (10) :1073-1081